Showing results (1821-1830 of 1,951) with videos related to
Sort By:
Pageof 196
Osteoarthritis and Cartilage|May 11, 2019
Evaluation of equine articular cartilage degeneration after mechanical impact injury using cationic contrast-enhanced computed tomographyB B Nelson, J T A Mäkelä, T B Lawson, et al.Scientific Reports|May 6, 2023
Mitochondrial citrate metabolism and efflux regulate BeWo differentiationRenee M Mahr, Snehalata Jena, Sereen K Nashif, et al.Cardiology|January 30, 2024
Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective IIIMeshal Alanezi, Andrew T Yan, Mary K Tan, et al.Plos One|September 20, 2022
Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemiaShengwen Zhang, Amy Bastille, Susana Gordo, et al.The Journal of General Virology|December 1, 2016
Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men studyShams Rahman, Christine M Pierce Campbell, Tim Waterboer, et al.Plos One|July 14, 2012
Hilar GABAergic interneuron activity controls spatial learning and memory retrievalYaisa Andrews-Zwilling, Anna K Gillespie, Alexxai V Kravitz, et al.Journal of Thoracic Disease|June 11, 2019
Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer DatabaseDavid B Nelson, David C Rice, Kyle G Mitchell, et al.Diabetes|February 26, 2011
Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient miceMalgorzata Wamil, Jenny H Battle, Sophie Turban, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching AnalysisDavid B Nelson, David C Rice, Jiangong Niu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokineticsMichael A Carducci, Joel B Nelson, M Kathy Bowling, et al.Pageof 196